Page last updated: 2024-10-22

aprindine and Parkinson Disease, Secondary

aprindine has been researched along with Parkinson Disease, Secondary in 1 studies

Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martí Massó, JF1
Carrera, N1
Urtasun, M1

Other Studies

1 other study available for aprindine and Parkinson Disease, Secondary

ArticleYear
Drug-induced parkinsonism: a growing list.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:1

    Topics: Aged; Antiemetics; Aprindine; Benzamides; Buformin; Female; Humans; Male; Middle Aged; Parkinson Dis

1993